| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nivedita Rattan, Laura Willmann, Diana Aston, Shani George, Milan Bassan, David Abi-Hanna, Sulakchanan Anandabaskaran, George Ermerak, Watson Ng and Jenn Hian Koo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jenn Hian Koo, FRACP, MBBS, PhD, Doctor, Doctor, Gastroenterology and Liver Services, Liverpool Hospital, Elizabeth Street, Liverpool 2170, New South Wales, Australia. jenn.koo@health.nsw.gov.au |
| Key Words |
Colorectal cancer; Adenoma; Screening; Fecal occult blood test; Colonoscopy |
| Core Tip |
Currently, there is minimal consensus to inform clinicians of the appropriate approach to manage patients presenting with positive immunochemical fecal occult blood test (iFOBT) following a recent colonoscopy. This may lead to additional unnecessary, invasive procedure which confers procedure-related risks, as well as avoidable patient anxiety and a higher cost-burden on the healthcare system. Our study revealed that a previous colonoscopy, irrespective of its result, was associated with low prevalence of advanced neoplasia, and if performed within 4 years of a positive iFOBT result, was protective against colorectal cancer. |
| Publish Date |
2022-09-09 12:48 |
| Citation |
Rattan N, Willmann L, Aston D, George S, Bassan M, Abi-Hanna D, Anandabaskaran S, Ermerak G, Ng W, Koo JH. To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World J Gastrointest Oncol 2022; 14(9): 1798-1807 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i9/1798.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i9.1798 |
